Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Halak Brian K
Relationship:   10% Owner
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   28    
Direct Shares   10,552,431    

Indirect Shares

   959,812      
Direct Value   $69,365,457    

Indirect Value

   $10,450,937      
Total Shares   11,512,243      
Total Value   $79,816,394      


Volcano Corp $0 Orexigen Therapeutics, Inc. $24 Vanda Pharmaceuticals Inc. $36,453 Esperion Therapeutics, Inc. $5,076,781 Evoke Pharma Inc $261,308 Veracyte, Inc. $58,001,541 Dicerna Pharmaceuticals Inc $983,401 Otonomy, Inc. $0 Atara Biotherapeutics, Inc. $9,029 Evofem Biosciences Inc $3,091,643 aTyr Pharma Inc $4,915 Glaukos Corp $719,661 Alimera Sciences Inc $100 Syndax Pharmaceuticals Inc $108,815 ReShape Lifesciences Inc $93,626 Bionano Genomics, Inc $917,638 Alliqua BioMedical Inc $60,523 Volcano Corp $0 Orexigen Therapeutics, Inc. $24 Vanda Pharmaceuticals Inc. $36,453 Esperion Therapeutics, Inc. $5,076,781 Evoke Pharma Inc $261,308 Veracyte, Inc. $58,001,541 Dicerna Pharmaceuticals Inc $983,401 Otonomy, Inc. $0 Atara Biotherapeutics, Inc. $9,029 Evofem Biosciences Inc $3,091,643 aTyr Pharma Inc $4,915 Glaukos Corp $719,661 Alimera Sciences Inc $100 Syndax Pharmaceuticals Inc $108,815 ReShape Lifesciences Inc $93,626 Bionano Genomics, Inc $917,638 Alliqua BioMedical Inc $60,523
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Northstar Neuroscience Inc NSTR Director 0 2006-05-04 3,333    Premium*  
            Cadence Pharmaceuticals Inc CADX 10% Owner 0 2014-03-19 0    Premium*  
            Volcano Corp VOLC 10% Owner 2008-04-24 3,415 2008-04-24 56,718    Premium*  
            Orexigen Therapeutics, Inc. OREX 10% Owner 2007-11-27 4,529 2011-12-22 50,643    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 0 2006-05-09 100,355    Premium*  
            Vanda Pharmaceuticals Inc. VNDA Director 2010-03-26 7,276 2010-03-26 0    Premium*  
            Achillion Pharmaceuticals Inc ACHN 10% Owner 0 2013-01-18 244,057    Premium*  
            Zogenix, Inc. ZGNX 10% Owner 2010-11-29 0 2011-09-16 169,251    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2011-11-21 0 2011-11-21 51,013    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 2014-11-17 0 2012-07-24 22,306    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 2015-03-20 2,216,935 2013-07-01 35,253    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2017-12-11 0 2013-07-15 55,296    Premium*  
            Tobira Therapeutics Inc TBRA 10% Owner 2016-11-01 0 2013-08-21 17,171    Premium*  
            Evoke Pharma Inc EVOK 10% Owner 2016-05-26 606,283 2013-09-30 24,256    Premium*  
            Veracyte, Inc. VCYT 10% Owner 2014-09-10 2,763,294 2013-11-04 22,730    Premium*  
            Tandem Diabetes Care Inc TNDM 10% Owner 2013-11-19 0 2013-11-19 54,390    Premium*  
            Dicerna Pharmaceuticals Inc DRNA Director 2017-12-18 25,730 2018-11-06 19,150    Premium*  
            Achaogen Inc AKAO 10% Owner 2014-03-17 0 2014-03-17 33,890    Premium*  
            Otonomy, Inc. OTIC 10% Owner 2014-08-18 11,715 2014-08-18 0    Premium*  
            Atara Biotherapeutics, Inc. ATRA 10% Owner 2014-10-21 15,890 2014-10-21 0    Premium*  
            Evofem Biosciences Inc EVFM 10% Owner 2014-11-25 3,091,643 2014-11-25 0    Premium*  
            aTyr Pharma Inc LIFE 10% Owner 2015-05-12 13,414 2015-05-12 0    Premium*  
            Glaukos Corp GKOS 10% Owner 2015-06-30 6,501 2015-06-30 0    Premium*  
            Alimera Sciences Inc ALIM Director 2021-09-17 327 2015-07-16 0    Premium*  
            Syndax Pharmaceuticals Inc SNDX 10% Owner 2016-03-08 5,641 2016-03-08 0    Premium*  
            ReShape Lifesciences Inc RSLS 10% Owner 2019-08-06 813,433 2016-10-12 0    Premium*  
            Bionano Genomics, Inc BNGO 10% Owner 2018-08-23 943,878 2018-08-23 0    Premium*  
            Alliqua BioMedical Inc ALQA 10% Owner 2019-05-03 22,527 0    Premium*  
* Premium Members only  

Records found :    152         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2018-06-07 4 D $14.45 $148,416 I/I (10,271) 25,810 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2016-04-19 4 S $5.36 $198,609 D/D (37,054) 959,922 0 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-08-14 4 B $8.00 $209,800 I/I 26,225 28,253 1.5 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2015-04-16 4 S $7.07 $229,146 D/D (32,411) 1,064,164 0 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-12-18 4 B $7.50 $285,750 I/I 38,100 42,761 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-11-24 4 B $6.75 $337,500 I/I 50,000 40,445 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-11-11 4 B $6.93 $371,448 I/I 53,600 31,858 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-11-12 4 B $6.90 $427,800 I/I 62,000 32,898 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-08-17 4 B $7.64 $482,856 I/I 63,201 29,313 1.5 -
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2018-11-05 4 S $12.98 $517,915 I/I (39,901) 19,922 0 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-11-10 4 B $6.93 $584,892 I/I 84,400 30,959 1.5 -
OTIC Otonomy, Inc. 10% Owner   –       –       •   2014-08-18 4 OE $8.79 $595,566 D/D 67,755 1,616,547 0 -
OTIC Otonomy, Inc. 10% Owner   –       –       •   2014-08-18 4 D $16.00 $595,584 D/D (37,224) 1,579,323 0 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2011-12-22 4 B $1.45 $680,263 I/I 469,147 50,643 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-12-17 4 B $7.55 $755,000 I/I 100,000 42,122 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-08-11 4 B $7.60 $792,680 I/I 104,300 20,887 1.5 -
EVFM Evofem Biosciences Inc 10% Owner   –       –       •   2014-11-25 4 B $14.00 $980,000 D/D 70,000 3,091,642 2.45 -
EVFM Evofem Biosciences Inc 10% Owner   –       –       •   2014-11-25 4/A B $14.00 $980,000 D/D 70,000 3,091,643 2.45 -
RSLS ReShape Lifesciences Inc 10% Owner   –       –       •   2019-08-06 4 B $4.00 $1,000,000 D/D 250,000 813,433 2.45 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-11-23 4 B $6.93 $1,039,500 I/I 150,000 39,606 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2008-12-08 4 B $4.47 $1,110,397 I/I 248,411 4,173 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2008-12-09 4 B $4.93 $1,192,518 I/I 241,890 8,237 1.5 -
TBRA Tobira Therapeutics Inc 10% Owner   –       –       •   2016-11-01 4 D $28.35 $1,349,829 D/D (47,613) 0 0 -
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2018-11-06 4 S $13.18 $1,376,513 I/I (104,328) 19,150 0 -
BNGO Bionano Genomics, Inc 10% Owner   –       –       •   2018-08-23 4 A $0.00 $1,550,015 D/D 928,878 929,878 0 -
  152  Records found
  1   2   3   4   5  6   7      
  Page 5 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us